Gentamicin C2b | CAS 52093-21-7 - Request Quote
Gentamicin C2b
| SZ CAT No: | SZ-G011005 |
| CAS No | 52093-21-7 |
| Mol.F. | C20H41N5O7 |
| Mol.Wt. |
463.6 |
| Inv. Status |
In Stock |
Enquire about - Gentamicin C2b
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Hazard Statement:
Usage Note:
Gentamicin C2b is chemically (2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4,6-Diamino-3-(((2R,3R,6S)-3-amino-6-((methylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-5-methyl-4-(methylamino)tetrahydro-2H-pyran-3,5-diol. Gentamicin C2b is supplied with detailed characterization data compliant with regulatory guideline. Gentamicin C2b can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gentamicin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 52093-21-7
Purchase 52093-21-7
Order 52093-21-7
Enquire 52093-21-7
price of 52093-21-7
52093-21-7 Supplier
52093-21-7 Manufacturer
52093-21-7 Exporter
buy high quality Gentamicin C2b
Purchase Gentamicin C2b
Gentamicin C2b suppliers
Gentamicin C2b manufacturers
Gentamicin C2b price
Order Gentamicin C2b
Enquire Gentamicin C2b
Gentamicin C2b cost
Gentamicin C2b Supplier
Gentamicin C2b Distributor
Gentamicin C2b for Method Validation
Gentamicin Reference Standard
Gentamicin C2b for ANDA Filing
Gentamicin C2b for Forced Degradation Studies
Gentamicin C2b Identification Standards
Gentamicin C2b for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.